{
  "id": 16200528,
  "title": "KFSH Advances Gene Therapy for Sickle Cell Disease Using Patients’ Own Modified Stem Cells",
  "url": "https://urgent.news/2026/10/23/kfsh-advances-gene-therapy-for-sickle-cell-disease-using-patients-own",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-23T15:09:18.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/kfsh-advances-gene-therapy-for-sickle-cell-disease-using-patients-own-modified-stem-cells"
  },
  "original_language": "en",
  "account": null,
  "summary": "RIYADH, Saudi Arabia, Oct. 23, 2026 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH) is advancing gene therapy for sickle cell disease through a 2026 clinical trial that uses the patient’s own hematopoietic stem cells, genetically modified to address the underlying defect and offer a potential path beyond repeated supportive treatment. The […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}